UCI study demonstrates the efficiency of wastewater-based epidemiology to monitor SARS-CoV-2

Alternative viral detection methods have been critical in the fight against COVID-19, helping to reduce the burden on our healthcare system. In a new study published in Applied and Environmental Microbiology, University of California, Irvine researchers demonstrate the efficiency of wastewater-based epidemiology (WBE) to monitor the presence and genetic diversity of SARS-CoV-2 among other viruses in Southern California.

COVID-19 mitigation strategies require accurate and affordable detection methods to help minimize the spread of SARS-CoV-2. Clinical-based detection methods remain the gold standard; however, WBE, which represents the collective waste of the human population in a given locale, can detect viral pathogens and potentially serve as an early warning detection system during a viral outbreak. Therefore, a better understanding of the ability of WBE to precisely detect and track viral pathogens could provide insights into the system's ability to serve as a valuable tool in the fight against infectious diseases like COVID-19.

Working with researchers at the Southern California Coastal Water Research Project, the UCI team monitored wastewater representing 16 million people in Southern California between August 2020 and January 2021.

When the pandemic hit, and we heard about wastewater monitoring efforts, we immediately thought of the wastewater collection in our lab that we were using to hunt for phages – viruses that infect bacteria and could be used as alternatives to antibiotics. I am proud of the team of students mobilized by Jason Rothman in our lab to process and concentrate the wastewater to search for viruses."

Katrine Whiteson, Ph.D., associate professor of molecular biology & biochemistry and co-corresponding author

In order to assay RNA viruses in several Southern California sewersheds, a research team led by Whiteson and Rothman, Ph.D., a Hewitt Foundation Postdoctoral Fellow, collected and analyzed 94 wastewater influent samples across seven treatment plants over five months. The wastewater samples were subjected to metatranscriptomic sequencing and droplet digital PCR to characterize RNA viromes and SARS-CoV-2 viral load.

The researchers found that the viral load of specific waste treatment plants correlated with the weekly average of reported COVID-19 cases in that county. Because the team gathered samples longitudinally, they confirmed that the relative abundance of SARS-CoV-2 increased throughout the study in specific plants. Additionally, the researchers optimized their purification technique and detected SARS-CoV-2 single nucleotide variants in certain samples.

"Our study shows the usefulness of wastewater-based epidemiology and its importance in helping monitor COVID-19 across Southern California," said Rothman, the study's first author and co-corresponding author.

During the study, the team determined that the wastewater samples were rich in viral diversity, with most viruses being plant-infecting. Other human viruses of interest remained prevalent throughout the pandemic, including norovirus. The diversity and composition were dependent on the location of the waste treatment plant, which was also the case for human pathogenic viruses like SARS-CoV-2. The team suggests that future studies continue to refine their sample preparation methods and more comprehensive monitoring to help determine how pathogenic viruses change over time.

"Our team was able to use cutting edge sequencing approaches to monitor not just the presence but also the diversity of wastewater representing 16 million people in Southern California," said Whiteson.

Journal reference:

Rothman, J.A., et al. (2021) RNA viromics of Southern California wastewater and detection of SARS-CoV-2 single nucleotide variants. Applied and Environmental Microbiology. doi.org/10.1128/AEM.01448-21.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How does SARS-CoV-2 cause lymphopenia when T cells barely express ACE-2 receptors?